ZYVERSA THERAPEUTICS, INC. Purchase Commitment, Remaining Minimum Amount Committed
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Purchase Commitment, Remaining Minimum Amount Committed of $265.96 thousand as of 2025-06-24, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2026-05-13
- 2025-06-24: Purchase Commitment, Remaining Minimum Amount Committed $265.96K.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2025-06-24 | $265.96K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |